Sentence examples for which also harbours from inspiring English sources

Instead, HKU16 contains a novel prophage termed ΦHKU.vir which also harbours ssa.

In addition, PgNAC15 clusters with clade c, which also harbours NST2, a gene involved in secondary wall thickening (Mitsuda et al., 2005).

It forms long coiled-coil homodimers of rod-like shape via its N-terminal domain of 190 kDa, which also harbours a short segment required for anchorage to the NPC (Bangs et al, 1998; Cordes et al, 1998; Hase et al, 2001).

In addition, it was convenient to introduce expression of the EWS-Oct-4B gene ectopically, because both the endogenous alleles of Oct-4 have been inactivated by gene targeting in the ZHBTc4 ES cell line, which also harbours the tetracycline-repressible mouse Oct-4 transgene (Niwa et al, 2000).

Of direct relevance to clinical resistance to alkylating agents were the observations of methylation in the mismatch repair gene MLH3 in Res259 cells, which also harboured high levels of promoter hypermethylation of MGMT, along with KNS42 cells.

The Auckland Islands are also only 270 km from the source islands of O. lyallii which also harbour large populations of nesting sea birds.

In melanomas, which also harbour BRAFV600E mutations, it has been demonstrated that BRAFV600E activates the MAPK pathway and controls proliferation of melanoma cells through the regulation of cyclin D1 and of the cyclin-dependent kinase inhibitor p27Kip1 [ 4- 7].

In addition, three silent mutations that did not alter the amino acid were identified in three hereditary breast cancer samples, of which two also harboured other missense mutations.

This region also harbours superoxide dismutase which has shown differential expression in WR 315 compared to JG 62 in infected state as well as zinc finger protein and translation initiation factor (Gupta et al. 2013).

Cdc42 cycling is modulated by ARHGAP10, a Rho GTPase- activating-protein (GAP) that also harbours an Arf-binding domain which is specific for Arf-GTP (ABD; [10], [11]).

In the total study population (n = 108), 15 heterozygous pathogenic mutations in 14 patients were identified (12.9 %; 95 % CI = 7.3 20.8 %): six in BRCA1, seven in BRCA2; two patients were found to carry CHEK2 c.1100delC of which one patient also harboured a deleterious BRCA2 mutation.